Detalles de la búsqueda
1.
Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease.
Therap Adv Gastroenterol
; 11: 1756284818759930, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29623105
Resultados
1 -
1
de 1
1
Próxima >
>>